Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats

Regulatory Peptides

Volumn 152, Issue 1-3, 2009, Pages 8-12

  Rudholm, T ^a   Wallin, B ^a   Theodorsson, E ^b   Naslund E ^c   Hellstrom P M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

Antagonist; Pentagastrin; Polyethylene glycol; Secretion

Indexed keywords

ESOMEPRAZOLE; GASTRAZOLE; GASTRIN ANTAGONIST; NEUROTENSIN; PENTAGASTRIN; RANITIDINE; SOMATOSTATIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACIDITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HORMONE RELEASE; HYPEROSMOLALITY; INTESTINE; INTESTINE PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH FISTULA;

ANIMALS; GASTRIC ACID; INTESTINAL SECRETIONS; MALE; NEUROTENSIN; OMEPRAZOLE; OSMOLAR CONCENTRATION; RANITIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; SOMATOSTATIN; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA; FISTULA; RATTUS;

EID: 57249113729     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.10.002     Document Type: Article

References (30)

1. Mogard M., Emås S., Nylander G., Wallin B., and Wallin C. Inhibition of pentagastrin-stimulated gastric acid secretion by upper intestinal hyperosmolality in chronic gastric fistula rats. Digestion 24 (1982) 183-189
2. Wallin C., Emås S., and Nylander G. Acid and hyperosmolal solutions in the upper intestine of chronic gastric fistula rats inhibit gastric acid secretion by different mechanisms. Scand J Gastroenterol 20 (1985) 1083-1090
3. Wallin C., Nylander G., and Emås S. Acid in proximal and distal duodenum inhibits, but hyperosmolal solution does not inhibit pentagastrin-stimulated acid secretion in chronic gastric fistula rats. Acta Physiol Scand 132 (1988) 577-581
4. Wallin C., and Emås S. Duodenal acidification and jejunal hyperosmolality inhibit pentagastrin-stimulated acid secretion in chronic gastric fistula rats. Scand J Gastroenterol 24 (1989) 1095-1101
5. Andersson S. Inhibitory effects of acid in the antrum-duodenum on fasting gastric secretion in Pavlov and Heidenhain pouch dogs. Acta Physiol Scand 49 (1960) 42-56
6. Wormsley K.G., and Grossman M.I. Inhibition of gastric acid secretion by secretion and by endogenous acid in the duodenum. Gastroenterology 47 (1964) 72-81
7. Konturek S., and Grossman M.I. Effect of perfusion of intestinal loops with acid, fat, or dextrose on gastric secretion. Gastroenterology 49 (1965) 481-489
8. Orloff S.L., Bunnett N.W., Walsh J.H., and Debas H.T. Intestinal acid inhibits gastric acid secretion by neural and hormonal mechanisms in rats. Am J Physiol 262 (1992) G165-170
9. Orloff S.L., Bunnett N.W., Wong H., Walsh J.H., and Debas H.T. Neural and hormonal mechanisms mediate the enterogastric reflex: a study in intestinal transplants in rats. Gastroenterology 101 (1991) 734-742
10. Nylander O., Bergqvist E., and Öbrink K.J. Dual inhibitory actions of somatostatin on isolated gastric glands. Acta Physiol Scand 125 (1985) 111-119
11. Schubert M.L., and Shamburek R.D. Control of acid secretion. Gastroenterol Clin North Am 19 (1990) 1-25
12. Emås S., Nylander G., and Wallin B. Comparison of the dose-response curves for acid output to pentagastrin determinated by two techniques in chronic gastric fistula rats. Digestion 22 (1981) 94-100
13. Larm O., Larsson R., and Olson P. A new thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Dev Artif Organs 11 (1983) 2-3
14. Emås S., Nylander G., Wallin B., and Wallin C. Inhibition of pentagastrin-stimulated gastric acid secretion by acid perfusion of the duodenum in chronic gastric fistula rats. Scand J Gastroenterol 18 (1983) 685-690
15. Grill C., Gutniak M., Roovete A., and Efendic S. A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 59 (1984) 293-297
16. Theodorsson-Norheim E., and Rosell S. Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion. Regul Pept 6 (1983) 207-218
17. Tebbe J.J., Mronga S., Schäfer M.K., Rüter J., Kobelt P., and Mönnikes H. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors. Am J Physiol 285 (2003) G1075-1083
18. García-Zaragozá E., Hernández C., Barrachina M.D., and Esplugues J.V. Interleukin 1 beta-induced inhibition of gastric acid secretion involves glutamate, NO and cGMP synthesis in the brain. Naunyn-Schmiedeberg's Arch Pharmacol 367 (2003) 22-27
19. Geoghegan J.G., and Pappas T.N. Central peptidergic control of gastric acid secretion. Gut 40 (1997) 164-166
20. El Munshid H.A., Håkanson R., Liedberg G., and Sundler F. Effects of various gastrointestinal peptides on parietal cells and endocrine cells in the oxyntic mucosa of rat stomach. J Physiol (Lond) 305 (1980) 249-265
21. Ben-Hamida A., Man W.K., and Spencer J. The effect of some gastrointestinal peptides on pentagastrin-stimulated acid secretion and oxyntic mucosal histamine in rats. Inflamm Res 45 (1996) S46-47
22. Grupcev G., Wallin C., Emås S., Theodorsson E., and Hellström P.M. Transforming growth factor-α and epidermal growth factor inhibit gastric acid secretion and stimulate release of somatostatin and neurotensin in the conscious rat. Regul Pept 52 (1994) 111-118
23. Wallin C., Grupcev G., Emås S., Theodorsson E., and Hellström P.M. Release of somatostatin, neurotensin and vasoactive intestinal peptide upon inhibition of gastric acid secretion by duodenal acid and hyperosmolal solutions in the conscious rat. Acta Physiol Scand 154 (1995) 193-203
24. Emås S., and Håkanson R. Intraduodenal instillation of acid and hyperosmolal solution suppresses pentagastrin-stimulated acid secretion but not histamine mobilization in the rat stomach. Scand J Gastroenterol 22 (1987) 776-780
25. Lucey M.R., Wass J.A., Fairclough P.D., O'Hare M., Kwasowski P., Penman E., Webb J., and Rees L.H. Does gastric acid release plasma somatostatin in man?. Gut 25 (1984) 1217-1220
26. Chen D., Friis-Hansen L., Håkanson R., and Zhao C.M. Genetic dissection of the signaling pathways that control gastric acid secretion. Inflammopharmacology 13 (2005) 201-207
27. Ferri G.L., Adrian T.E., Soimero L., Blank M., Cavalli D., Biliotti G., Polak J.M., and Bloom S.R. Intramural distribution of immunoreactive vasoactive intestinal polypeptide (VIP), substance P, somatostatin and mammalian bombesin in the oesophago-gastro-pyloric region of the human gut. Cell Tissue Res 256 (1989) 191-197
28. Berner B.D., Conner C.S., Sawyer D.R., and Siepler J.K. Ranitidine: a new H2-receptor antagonist. Clin Pharm 1 (1982) 499-509
29. Chau I., Cunningham D., Russell C., Norman A.R., Kurzawinski T., Harper P., Harrison P., Middleton G., Daniels F., Hickish T., Prendeville J., Ross P.J., Theis B., Hull R., Walker M., Shankley N., Kalindjian B., Murray G., Gillbanks A., and Black J. Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials. Br J Cancer 94 (2006) 1107-1115
30. Buck I.M., Black J.W., Cooke T., Dunstone D.J., Gaffen J.D., Griffin E.P., Harper E.A., Hull R.A., Kalindjian S.B., Lilley E.J., Linney I.D., Low C.M., McDonald I.M., Pether M.J., Roberts S.P., Shankley N.P., Shaxted M.E., Steel K.I., Sykes D.A., Tozer M.J., et al. Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists. J Med Chem 48 (2005) 6803-6812